Article
Targeting lysosomal pH restores mitochondrial quality control in GBA1-mutant Parkinson's disease.
Translational neurodegeneration - 17 Jun 2026
Sheshadri Preethi, Costa-Besada Maria Alicia, Fisher Alessia, Kiraly Szilvia, Singh Kritarth, Kourouzidou Ioanna, Blacker Thomas S, Zeng Jialiu, Shirihai Orian S, Grinstaff Mark W, Duchen Michael R
Abstract excerpt
BACKGROUND: Heterozygous mutations in the glucocerebrosidase gene (GBA1), which encodes the lysosomal enzyme β-glucocerebrosidase (GCase), are a genetic risk factor for Parkinson's disease (PD). The pathophysiological consequences of GBA1 mutations on dopaminergic neuronal function, especially their impact on lysosomal function, mitophagy, and mitochondrial bioenergetics, remain unclear. METHODS: Fibroblasts and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
